Open AccessHalf- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005)
Author(s) -
Renata J.M. Engler
Publication year - 2008
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2008.513
Subject(s) - medicine , hemagglutination assay , titer , vaccination , influenza vaccine , confidence interval , immunogenicity , seroconversion , immunization , antibody titer , inactivated vaccine , immunology , antibody
Optimal public health strategies for managing influenza vaccine shortages are not yet defined. Our objective was to determine the effects of age, sex, and dose on the immunogenicity of intramuscular trivalent inactivated vaccine (TIV).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom